IMO I think some are thinking the wrong way about the unexercised Bonus Options.
I suggest you direct any frustration at those who failed to exercise their options and not RAC or Dr T or the Board.
Fact 1: The Bonus and Piggy Options are both well in the money.
Fact 2: We can only ponder why some investors fail to exercise.
Fact 3: RAC needs to raise money to run their planned trials.
Fact 4: RAC offered the capital raise to all their investors. i.e to look after loyal holders including Retail.
Fact 5: If RAC needs extra funds to drive the trials after expiry of the Bonus Options, their cheapest and quickest path to do that is with Sophs and Institutions. i.e. we have to assume that any decision to raise further funds and drive the trails will be in the best interests of shareholders.
Fact 6: RAC need to wait until expiry of the Bonus Options before a decision can be made. i.e. what is the result of the Bonus Option take up?
Cheers
- Forums
- ASX - By Stock
- Ann: Application for quotation of securities - RAC
RAC
race oncology ltd
Add to My Watchlist
3.38%
!
$1.15

IMO I think some are thinking the wrong way about the...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$1.15 |
Change
-0.040(3.38%) |
Mkt cap ! $198.9M |
Open | High | Low | Value | Volume |
$1.22 | $1.22 | $1.13 | $132.0K | 114.0K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 2390 | $1.14 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.18 | 4805 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 2390 | 1.140 |
3 | 5274 | 1.135 |
4 | 7220 | 1.130 |
1 | 2008 | 1.125 |
5 | 14965 | 1.120 |
Price($) | Vol. | No. |
---|---|---|
1.180 | 4805 | 1 |
1.205 | 2500 | 1 |
1.220 | 21445 | 4 |
1.230 | 7500 | 2 |
1.245 | 2000 | 1 |
Last trade - 15.57pm 04/07/2025 (20 minute delay) ? |
Featured News
RAC (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Dr Michael Thurn, CEO & MD
Dr Michael Thurn
CEO & MD
SPONSORED BY The Market Online